Cardiology
News
Thirty-second atrial fib threshold may drive overdiagnosis
BOSTON – The current 30-second threshold for defining clinically meaningful AF “metastasized” from a select subgroup of patients to all AF...
News
First reversal agent for apixaban and rivaroxaban gets fast-track approval
Andexanet alfa approval puts factor Xa inhibitors in the same ballpark as dabigatran, reversible with idarucizumab.
News
Does warfarin cause acute kidney injury?
SAN DIEGO – Consider increased monitoring of renal function in certain patients.
Clinical
How should asymptomatic hypertension be managed in the hospital?
The appropriate treatment of hypertension in the inpatient setting is suboptimal due to the lack of guidelines and inconsistent management.
Clinical
Noninvasive cardiac testing to rule out acute coronary syndromes provides no benefit in low-risk chest pain patients
Does clinical evaluation and noninvasive cardiac testing improve outcomes in patients who present to the emergency department (ED) with acute...
Clinical
Lower risk of ICH with dabigatran as compared to warfarin in atrial fibrillation
Is dabigatran superior to warfarin with regards to the risk of intracranial hemorrhage and myocardial infarction in patients with atrial...
News
Impaired kidney function no problem for dabigatran reversal
ORLANDO – Idarucizumab, reversal agent for the anticoagulant dabigatran, worked fine in patients with renal dysfunction.
News
24-hour ambulatory BP measurements strongly predict mortality
Masked hypertension identified by 24-hour monitoring carried the greatest risk of death.
Clinical
High 5-year mortality in patients admitted with heart failure regardless of ejection fraction
Are there differences in 5-year outcomes in patients hospitalized with heart failure with preserved ejection fraction (ejection fraction [EF],...
Clinical
Short Takes
Iron supplement dosing; immediate PCI